LAVIPHARM S.A. NA EO 1 (BXA0) — Cash Flow Quality Index
LAVIPHARM S.A. NA EO 1 (BXA0) has a Cash Flow Quality Index of 0.52x as of December 2024. Operating cash flow of €4.64 Million is below net income of €8.98 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore BXA0 asset base for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
LAVIPHARM S.A. NA EO 1 Cash Flow Quality Index (2021–2024)
Historical Cash Flow Quality Index for LAVIPHARM S.A. NA EO 1 across 4 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check LAVIPHARM S.A. NA EO 1 (BXA0) tangible net worth to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for LAVIPHARM S.A. NA EO 1 (2021–2024)
Year-by-year earnings quality comparison for LAVIPHARM S.A. NA EO 1. For live market cap and the full company financial profile, see how much is LAVIPHARM S.A. NA EO 1 worth.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.52x | €4.64 Million | €8.98 Million | ▲ +240.3% |
| 2023 | 0.15x | €284.00K | €1.87 Million | ▼ -96.2% |
| 2022 | 4.01x | €3.35 Million | €834.00K | ▲ +68.2% |
| 2021 | 2.38x | €4.11 Million | €1.72 Million | — |